Ardea Outcomes

Generating personalized evidence through Goal Attainment Scaling (GAS) in clinical development.

[Ardea Outcomes @ArdeaOutcomes]

We are excited and ready for #ISPOREurope! Stop by our booth #527 to chat with our team and CEO about #GoalAttainmentScaling and learn how we can assist your organization in implementing this #personalizedendpoint in #clinicaldevelopment. We look forward to seeing you there!

[Ardea Outcomes @ArdeaOutcomes]

#ISPOR Europe! We are excited to connect with peers and industry leaders and engage in insightful discussions about #GoalAttainmentScaling (GAS) and clinical outcomes. Don't miss our podium presentation on Monday, the 18th, at 2:30 PM.
#ISPOR #ISPOREU #Clinicaloucomes #endpoints

[Ardea Outcomes @ArdeaOutcomes]

#ISOQOL Don't miss our upcoming workshop tomorrow in partnership with IQVIA at Salon 17 Darmstadt from 1:00–4:00 PM. Get to learn more about #GoalAttainmentScaling. Looking forward to seeing you there!

[RARE Revolution Magazine® @RareRevolutionM]

The “cutting-edge” approach of #GoalAttainmentScaling has the power to give the patient a voice in decision-making and to deliver truly patient-centred #ClinicalTrials, says Chere Chapman, co-founder and CEO at @ArdeaOutcomes. Read more here:
https://t.co/LZ6mjIehWg

[Ardea Outcomes @ArdeaOutcomes]

Excited about the new #publication on #GoalAttainmentScaling (GAS) in #dementia care, co-authored by Dr. @Krockdoc, @ClaudiaACooper1, highlighting the NIDUS Family intervention's positive impact on achieving personalized goals.
https://t.co/j0gYvSmO3M
#NIDUSFamily #Dementia

[Ardea Outcomes @ArdeaOutcomes]

Last April, we launched our first Ardea Outcomes Monthly Edit. Our newsletter features the most recent #GoalAttainmentScaling (GAS) scientific updates and team news. Make sure to sign up for our GAS newsletter to get the latest news!
https://t.co/2yLG54fkB2
#newsletters

[Ardea Outcomes @ArdeaOutcomes]

🚀 We’re excited to see the EU-US @CTAD Task Force highlight #GoalAttainmentScaling as a novel, personalized outcome measure in their recent publication! Thanks to the authors for advancing innovative approaches to #Alzheimer's research. 🧠📊 Read more: https://t.co/S9RgcN0py9

[Ardea Outcomes @ArdeaOutcomes]

Last April, we launched our first Ardea Outcomes Monthly Edit. Our newsletter features the most recent #GoalAttainmentScaling (GAS) scientific updates and team news. Make sure to sign up for our GAS newsletter to get the latest news!
https://t.co/2yLG54fkB2
#newsletters

[Ardea Outcomes @ArdeaOutcomes]

Heading to #ISPORannual? Join us on May 6th for our poster presentation and meet our CEO, Chere Chapman! We would love to discuss everything #GoalAttainmentScaling (GAS)and how it can be utilized as a personalized endpoint.
#ISPOR #Clinicaltrials #GoalAttainmentScale #endpoints

[Ardea Outcomes @ArdeaOutcomes]

We look forward to #ISPORAnnual in Atlanta, GA. Join us for our poster presentation! Our team will present a review of Goal Attainment Scaling (GAS) implementation as a personalized clinical outcome assessment over the Last Decade.
#conferences #ISPOR #goalattainmentscaling

[Ardea Outcomes @ArdeaOutcomes]

New #Publication Alert🚨 📝
We conducted a systematic review of studies that implemented #GoalAttainmentScaling (GAS) with caregiver input and examined variations in the implementation, analysis, and reporting of GAS in these studies. Access here: https://t.co/VL7sw9sGsj

[Exactis Innovation @ExactisI]

🚨 New release of #WhatsWithRWE! We spoke with Chere Chapman, CEO of @ArdeaOutcomes, a Canadian CRO focusing on goal attainment scaling (GAS) in #clinicaltrials. Watch the short video below (5 min) as Chere dives into the genesis of the organization.
https://t.co/l3XbhPySBZ

[Ardea Outcomes @ArdeaOutcomes]

Excited to see this cutting-edge research from our Co-Founder & President @Krockdoc, @ClaudiaACooper1, and colleagues at @UCL outlining the novel use of #GAS to support independent living in #Alzheimer's disease in the UK.
#personalizedendpoints https://t.co/ALTNmLCYzZ

[Ardea Outcomes @ArdeaOutcomes]

#InternationalWomensDay! Today we celebrate all women contributing to scientific research and impacting lives. As a women-led company, we're proud to have @ChereChapman at the helm and a 60% female workforce. #IWD2024 #inclusion #womeninstem https://t.co/VyUjQsK1NK

[Ardea Outcomes @ArdeaOutcomes]

We're gearing up for @OrphanConf in April. Our #abstracts have been submitted, and we’re preparing our workshop with @trendcommunity on personalized endpoints in #PraderWilli Syndrome. Join us in Boston! #patientcenteredoutcomes #sociallistening #raredisease #partnership

[Ardea Outcomes @ArdeaOutcomes]

#Throwback to one example evaluating the utility of #GoalAttainmentScaling (GAS) as an outcome measure in Alzheimer's disease. We explored GAS’s sensitivity to change, allowing it to detect small but menaingfulchanges. #personalizedendpoints #COAs
https://t.co/exDWGvQA0n

[Ardea Outcomes @ArdeaOutcomes]

In our recent collaboration with the InchStone project, we explored clinical trial readiness in rare DEEs through the lens of patient-focused drug development guidelines and #personalizedendpoints.
Read the full publication here: https://t.co/tRyv8xkNla

#PFDD #Raredisease #GAS

[Ardea Outcomes @ArdeaOutcomes]

Warm wishes from our company to all our valued partners and dedicated employees! May this holiday season bring joy and warmth to your hearts. Here's to a joyful celebration and a prosperous new year in 2024! #Holidays #Newyear #2024

[Ardea Outcomes @ArdeaOutcomes]

Our collaboration with the @DEE_Pconnection and @FamilieSCN2A sought to describe what meaningful change means in individuals affected by severe SCN2A-related developmental and epileptic encephalopathy.
#DEEs #raredisease #Goalattainmentscaling
https://t.co/Ds4F0L7h29

[Ardea Outcomes @ArdeaOutcomes]

Watch our Research Manager, Gunes Sevinc, outline strategies to standardize the implementation of Goal Attainment Scaling as a personalized endpoint in clinical development. #webinars #PFDD #Goalattainmentscaling #personalizedendpoints
Watch full webinar:https://t.co/sdB0EWFmjB